Pain Reprocessing Therapy (PRT) in a Specialist Pain Clinic: A Feasibility Study
Breaking the Pain Cycle: Implementing a Novel Neuroscience-based Behavioral Therapy for Chronic Pain in a Pain Rehabilitation Setting
Long-term pain, which is pain that lasts for more than three months, is a major health problem. It can severely impact a person's physical and mental well-being, quality of life, and ability to work. It also carries high costs for society, mainly due to high rates of sick leave.
For many people with long-term pain, there is no clear injury or disease that fully explains why it hurts. In these cases, the pain is believed to be caused by how the brain and nervous system process pain signals. This is sometimes called "nociplastic pain."
Even though there are many treatments for pain-like medications and therapies-they don't work for everyone, and many people are left without meaningful relief. Because of this, it is important to find and test new ways to treat pain. In this study, the investigators evaluate a relatively new psychological treatment called Pain Reprocessing Therapy (PRT), which has been tested in the US with promising results.
PRT helps individuals with chronic pain to understand and change how they think about their pain by explaining how the brain works. The treatment focuses on teaching the difference between acute (new) pain and long-term pain. It also involves exercises to help people alter emotions related to their pain. A key part of the treatment is a technique where patients practice paying attention to what is happening in their bodies in a safe, relaxed way. The goal is to teach the brain that the pain signals are not a threat. This can help break the vicious cycle of fear, avoiding activities, and worsening pain.
While many people are interested in treatments like PRT, it hasn't yet been tested in specialized care for patients with complex pain. This trial is a pilot study-a smaller, initial investigation to evaluate how well the treatment works in a clinical setting, and to determine if both patients and therapists find it acceptable and practical to use. This will give us important information to help prepare for larger studies in the future.
The main goal of this pilot study is to see if PRT is a practical and accepted treatment in a Swedish pain rehabilitation setting. The investigators also want to look at whether the treatment helps reduce pain, psychological distress, negative thoughts about pain, and the fear of moving. Finally, the investigators will explore how a patient's expectations and thinking skills (such as memory and focus) might affect how well the treatment works, and take physical measurements before and after the treatment to see if the nervous system becomes better at regulating pain.
Přehled studie
Postavení
Postavení
Podmínky
Podmínky
Intervence / Léčba
Intervence / Léčba
Detailní popis
The overall aim of this project is to conduct a pilot study investigating the feasibility, patient satisfaction, and acceptability of a recently developed psychological treatment for pain: Pain Reprocessing Therapy (PRT). The study will be conducted within a clinical pain rehabilitation setting, where patients frequently present with severe pain, psychiatric comorbidity, and reduced or absent work capacity.
Within the framework of this project, the investigators will evaluate whether PRT can be effectively implemented in a pain rehabilitation context and whether the treatment is perceived as acceptable and feasible by both patients and clinicians. Furthermore, the investigators intend to conduct exploratory analyses to determine if specific clinical subgroups appear more responsive to the intervention.
A secondary aim is to evaluate changes in pain intensity, functional capacity, fear of movement (kinesiophobia), pain catastrophizing, as well as symptoms of anxiety and depression. Although study participants will not be randomized, the results will be compared to a matched reference group drawn from the Swedish Quality Registry for Pain Rehabilitation (SQRP). This reference group, comprising individuals who have undergone standard multimodal pain rehabilitation, is included to provide a contextualizing indication of whether PRT is associated with clinically relevant changes in the outcome measures.
The project is designed as a single-arm pilot study in which all participants will receive PRT. Data collection will occur at baseline, during the intervention, and post-treatment. PRT, which has previously been evaluated primarily in a selected population with chronic back pain and limited comorbidity, aims to modify the patient's interpretation of the cause of their pain and its perceived threat value. By targeting fear-avoidance responses triggered by somatic signals, the ultimate objective of the treatment is to facilitate sustained symptom relief.
Primary Objective:
The primary objective is to investigate whether a 9-week treatment with Pain Reprocessing Therapy (PRT) meets predefined criteria for feasibility and acceptability.
Primary Research Questions:
- Is an adequate recruitment rate achieved among approached patients?
- Does a sufficiently large proportion of the included participants complete the treatment program (retention rate)?
- Does the treatment demonstrate adequate patient satisfaction?
- Are patient attendance and treatment adherence, in terms of completing homework assignments, consistent with predefined benchmarks?
- Do the clinicians demonstrate adequate treatment fidelity to the PRT manual?
Secondary Objective:
The secondary objective is to exploratively investigate whether PRT is associated with changes in predefined clinical outcome measures.
Secondary Research Questions:
- Are there observed changes in self-rated pain experience, quality of life, symptoms of anxiety and depression, fear of movement (kinesiophobia), pain-related catastrophizing, fatigue and sickness behavior?
- How do changes in outcome measures following PRT compare to a matched reference group that has undergone standard multimodal pain rehabilitation?
Exploratory Research Questions:
- Are participants' initial treatment expectations and perceived credibility , as well as their perception of clinician empathy, cognitive functioning and pain sensitivity associated with treatment outcomes?
- How are cognitive function and pain sensitivity affected by the treatment?
- How do participants describe their experiences of the treatment and perceived processes of change in qualitative interviews?
Typ studie
Typ studie
Zápis (Odhadovaný)
Zápis
Fáze
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
-
Stockholm, Švédsko
- Nábor
- Karolinska Institutet
-
Kontakt:
- Andreas Hellerström
- Telefonní číslo: +46704535889
- E-mail: andreas.hellerstrom@ki.se
-
-
Kritéria účasti
Kritéria způsobilosti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
- Adults aged 18 years and older.
- Completed medical investigation regarding the pain diagnosis. Primary pain conditions (according to ICD-11) or nociplastic pain, as well as mixed conditions where patients have nociplastic pain combined with nociceptive and/or neuropathic pain (e.g., fibromyalgia, chronic widespread pain, primary chronic back pain).
- Pain duration of at least 3 months.
- Current medication regimen compatible with participating in and benefiting from highly specialized rehabilitation.
- Ability to read, speak, and understand the Swedish language.
- Exclusion Criteria:
- Severe psychiatric conditions (e.g., psychosis, severe depression, and suicidality).
- Current substance abuse (including overuse of prescription medications) or dementia.
- Cancer pain, cauda equina syndrome, or other medical conditions that constitute the primary explanation for the patient's pain.
- Another psychological treatment for pain within the past 3 months.
- Ongoing parallel treatments related to the patient's pain at other clinics, with the exception of ongoing pharmacological treatment.
- Ongoing legal disputes or active claims for disability compensation.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: N/A
- Intervenční model: Přiřazení jedné skupiny
- Maskování: Žádné (otevřený štítek)
Počet zbraní
Zbraně a zásahy
Skupina účastníků / ArmSkupina účastníků / Arm |
Intervence / LéčbaIntervence / Léčba |
|---|---|
|
Experimentální: Pain Reprocessing Therapy
|
A 9-week intervention with 9 individual sessions and 3 group sessions based on Pain Reprocessing Therapy.
|
Co je měření studie?
Primární výstupní opatření
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Retention rate
Časové okno: From enrollment to 9 weeks (post treatment).
|
The retention rate is defined as the percentage of participants who successfully complete the PRT intervention.
To be considered a completer, a participant must attend at least 6 of the 9 individual sessions and complete all post-treatment outcome measures.
The benchmark for study feasibility is set at 75%
|
From enrollment to 9 weeks (post treatment).
|
|
Recruitment rate
Časové okno: From study start to recruitment completion, an estimated 6 months
|
Feasibility of recruitment, defined as percentage of eligible participants who give informed consent and are enrolled in the study.
The predefined benchmark for feasibility of recruitment rate is set as at least 70%
|
From study start to recruitment completion, an estimated 6 months
|
|
Patient treatment satisfaction
Časové okno: Post treatment (9 weeks)
|
Assessed using the Client Satisfaction Questionnaire (CSQ-8).
The total score ranges from 8 to 32.
Higher scores indicate greater satisfaction with the treatment received, representing a better outcome.
The predefined benchmark for acceptability is set to a mean total score of 24 or higher (out of a maximum of 32).
|
Post treatment (9 weeks)
|
|
Adherence to treatment
Časové okno: From enrollment to the end of the treatment at 9 weeks
|
Adherence to the in-between session work with home assignments, as logged by the therapists during the 9-week program.
The predefined benchmark for adequate adherence is at least 70% of assigned homework tasks.
|
From enrollment to the end of the treatment at 9 weeks
|
|
Therapists treatment fidelity
Časové okno: From treatment start to the end of treatment at 9 weeks
|
The degree to which the therapists adhere to the core interventions of the treatment.
Evaluated by therapist self-report using a study-specific PRT fidelity checklist completed after each session.
The predefined benchmark for adequate treatment fidelity is set to an average adherence score of at least 80%.
|
From treatment start to the end of treatment at 9 weeks
|
Sekundární výstupní opatření
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Pain Catastrophizing Scale (PCS)
Časové okno: Baseline and week 9
|
The PCS assesses negative thoughts and emotions associated with past, present or anticipated pain.
The total score ranges from 0 to 52.
Higher scores indicate greater levels of pain catastrophizing.
|
Baseline and week 9
|
|
Tampa Scale of Kinesiophobia (TSK)
Časové okno: Baseline and week 9
|
The TSK assesses fear of movement or re-injury.
The 17-item version is used.
Total scores range from 17 to 68.
Higher scores indicates a higher degree of kinesiophobia.
|
Baseline and week 9
|
|
Hospital Anxiety and Depression Scale (HADS)
Časové okno: Baseline and week 9
|
The HADS scale measures anxiety and depression symptoms.
The HADS contains of 14 items, divided into 2 subscales (anxiety and depression).
For each subscale, the total score ranges from 0 to 21.
Higher scores indicate greater severity of anxiety and depression symptoms.
|
Baseline and week 9
|
|
EQ-5D
Časové okno: Baseline and week 9 (post treatment)
|
The EQ-5D measures health-related quality of life across five dimensions.
Responses are converted into a single index score.
The index score typically ranges from a minimum of less than 0 (often around -0.59, representing a health state worse than death) to a maximum of 1.0 (representing full health).
Higher index scores indicate a better health-related quality of life.
|
Baseline and week 9 (post treatment)
|
|
EQ-5D VAS
Časové okno: Baseline to 9 week (post treatment)
|
Measures self-rated overall health using a Visual Analogue Scale (EQ-VAS).
Participants rate their overall health using a vertical visual analogue scale rangeing from 0-100.
Higher scores indicates a better self-percieved health.
|
Baseline to 9 week (post treatment)
|
|
Sickness Questionnaire (SicknessQ)
Časové okno: Baseline and week 9.
|
The SicknessQ assesses self-reported sickness behavior (e.g., fatigue, social withdrawal.
The scores ranges from 0 tp 30.
Higher scores indicate a higher degree of sickness behavior.
|
Baseline and week 9.
|
|
Multidimensional Fatigue Inventory (MFI-20)
Časové okno: Baseline to 9-week (post treatment)
|
The MFI-20 assesses five dimensions of fatigue.
The total score ranges from 20-100 where higher scores indicate higher levels of fatigue.
|
Baseline to 9-week (post treatment)
|
|
Numeric Rating Scale For Pain
Časové okno: Baseline and week 9 (Post treatment)
|
The NRS measures pain intensity where participants rate their pain intensity during the past week on an 11 point scale from 0 to 10. Higher scores indicate worse pain intensity.
|
Baseline and week 9 (Post treatment)
|
|
Consultation and Relational Empathy Measure (CARE)
Časové okno: Week 2 and 9 (post treatment)
|
The CARE-scale assesses the participants perception of the therapists empathy during sessions.
The maximum score is 50.
Higher scores indicate greater percieved empathy from the treating clinician
|
Week 2 and 9 (post treatment)
|
|
Credibility/Expectancy Questionnaire (CEQ)
Časové okno: Week 2
|
The CEQ assesses how logical the treatment seems to the patient, and how much improvement they expect.
Scores for each subscale range from 3 to 27.
Higher scores indicate higher perceived credibility and expectancy of clinical improvement.
|
Week 2
|
Další výstupní opatření
Další výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Pressure Pain Threshold (PPT)
Časové okno: Baseline and 9-week
|
Assessed using a pressure algometer.
Measures are recorded in kPa at predefined anatomical sites.
Higher values indicate higher pain thresholds.
|
Baseline and 9-week
|
|
Thermal Pain Thresholds
Časové okno: Baseline and week 9 (Post treatment)
|
Assessed using a computerized thermotest device.
Heat Pain Threshold (HPT) and Cold Pain Threshold (CPT) are measured in degrees Celcius.
For HPT, higher temperatures indicate a higher pain threshold.
For CPT, lower temperatures indicate a higher pain threshold.
|
Baseline and week 9 (Post treatment)
|
|
PrePain Questionnaire
Časové okno: Before treatment start and 9 weeks (post treatment)
|
The PrePain questionnaire assesses attitudes, emotions and behaviors related to pain.
The six dimensional questions (assessing perceived pain-sensitivity, avoidance, distress, relief, focus on symptoms, and negative thoughts) are analyzed individually rather than as a total score.
Each item is scored on a Visual Analog Scale (VAS) with a minimum value of 0 and a maximum value of 100.
A VAS-score of 100 means respectively low pain-sensitivity, low degree of avoidance, low degree of distress, low degree of relief, low degree focus on symptoms and low degree of negative thoughts.
Because higher scores represent a lower degree of these pain-related attitudes and emotions, higher scores indicate a better outcome.
|
Before treatment start and 9 weeks (post treatment)
|
|
Stroop-test
Časové okno: Baseline and 9 weeks (post treatment)
|
Executive control, attention, and inhibition are assessed using a digital version of the Stroop test administered via the 'Health Catcher' application.
Participants are instructed to respond to the color of a written word rather than the word itself.
Performance is measured by the total number of correct responses completed within a 90-second time limit.
The minimum possible score is 0. There is no predefined maximum score, as the total number of items presented depends on the participant's response speed.
Higher scores (more correct responses within the time limit) indicate better cognitive performance and inhibition.
|
Baseline and 9 weeks (post treatment)
|
|
Go/no-go Test
Časové okno: Baseline and 9 weeks (post treatment)
|
Sustained attention and response inhibition are assessed using a digital Go/no-go test administered via the 'Health Catcher' application.
Participants respond to a target stimulus while withholding responses to a non-target stimulus.
Performance is measured by the total number of correct responses completed within a 90-second time limit.
The minimum possible score is 0. There is no predefined maximum score, as the total number of items presented depends on the participant's response speed.
Higher scores (more correct responses within the time limit) indicate better sustained attention and response inhibition.
|
Baseline and 9 weeks (post treatment)
|
|
Verbal Recognition Memory Test
Časové okno: Baseline and 9 weeks (post treatment)
|
Verbal episodic memory is assessed using a digital verbal recognition memory test administered via the 'Health Catcher' application.
Participants report whether mixed lists of words were included in a previously presented sequence.
Performance is measured by the total score of correct recognitions.
The score ranges from a minimum of 0 to a maximum of 24.
Higher scores indicate better memory function.
|
Baseline and 9 weeks (post treatment)
|
|
Visual Working Memory Test
Časové okno: Baseline and 9 weeks (post treatment)
|
Visuospatial working memory and attention are assessed using a digital visual working memory test administered via the 'Health Catcher' application.
Participants memorize and reproduce sequences of illuminated squares in a 4x4 grid.
Performance is measured by the total score of correctly identified locations.
The score ranges from a minimum of 0 to a maximum of 6.
Higher scores indicate better visuospatial working memory, representing a better outcome
|
Baseline and 9 weeks (post treatment)
|
Spolupracovníci a vyšetřovatelé
Sponzor
Sponzor
Spolupracovníci
Spolupracovníci
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Odhadovaný)
Začátek studia
Primární dokončení (Odhadovaný)
Primární dokončení
Dokončení studie (Odhadovaný)
Dokončení studie
Termíny zápisu do studia
První předloženo
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
První zveřejněno
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Poslední zveřejněná aktualizace
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
Další identifikační čísla studie
- 2026-01099-01
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .